Cargando…

Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases

BACKGROUND: To evaluate functional visual parameters using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by central or peripheral scotoma due to retinal diseases. Sixty patients were enrolled in this study: 30 patients affected by central scotoma, group...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, L., Melardi, E., Ferri, P., Montesano, G., Samir Attaalla, S., Patelli, F., De Cillà, S., Savaresi, G., Rossetti, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568170/
https://www.ncbi.nlm.nih.gov/pubmed/28830379
http://dx.doi.org/10.1186/s12886-017-0545-9
_version_ 1783258805840117760
author Colombo, L.
Melardi, E.
Ferri, P.
Montesano, G.
Samir Attaalla, S.
Patelli, F.
De Cillà, S.
Savaresi, G.
Rossetti, L.
author_facet Colombo, L.
Melardi, E.
Ferri, P.
Montesano, G.
Samir Attaalla, S.
Patelli, F.
De Cillà, S.
Savaresi, G.
Rossetti, L.
author_sort Colombo, L.
collection PubMed
description BACKGROUND: To evaluate functional visual parameters using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by central or peripheral scotoma due to retinal diseases. Sixty patients were enrolled in this study: 30 patients affected by central scotoma, group 1, and 30 affected by peripheral scotoma, group 2. Black on White Best Corrected Visual Acuity (BW-BCVA), White on Black Best Corrected Visual Acuity (WB-BCVA), Mars Contrast Sensitivity (CS) and a Glare Test (GT) were performed to all patients. Test results with blue-violet filter, a short-pass yellow filter and with no filters were compared. RESULTS: All scores from test results increased significantly with blue-violet filters for all patients. The mean BW-BCVA increased from 0.30 ± 0.20 to 0.36 ± 0.21 decimals in group 1 and from 0.44 ± 0.22 to 0.51 ± 0.23 decimals in group 2 (Mean ± SD, p < 0.0001 in both cases). The mean WB-BCVA increased from 0.31 ± 0.19 to 0.38 ± 0.23 decimals in group 1 and from 0.46 ± 0.20 to 0.56 ± 0.22 decimals in group 2 (Mean ± SD, p < 0.0001 in both cases). The letter count for the CS test increased from 26.7 ± 7.9 to 30.06 ± 7.8 in group 1 (Mean ± SD, p = 0.0005) and from 31.5 ± 7.6 to 33.72 ± 7.3 in group 2 (Mean ± SD, p = 0.031). GT was significantly reduced: the letter count increased from 20.93 ± 5.42 to 22.82 ± 4.93 in group 1 (Mean ± SD, p < 0.0001) and from 24.15 ± 5.5 to 25.97 ± 4.7 in group 2 (Mean ± SD, p < 0.0001). Higher scores were recorded with the Blue filter compared to Yellow filter in all tests (p < 0.05). No significant differences in any test results could be detected between the Yellow filter and the No filter condition. CONCLUSIONS: The use of a combination of photocromic lens with a selective blue-violet light filter showed functional benefit in all evaluated patients.
format Online
Article
Text
id pubmed-5568170
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55681702017-08-29 Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases Colombo, L. Melardi, E. Ferri, P. Montesano, G. Samir Attaalla, S. Patelli, F. De Cillà, S. Savaresi, G. Rossetti, L. BMC Ophthalmol Research Article BACKGROUND: To evaluate functional visual parameters using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by central or peripheral scotoma due to retinal diseases. Sixty patients were enrolled in this study: 30 patients affected by central scotoma, group 1, and 30 affected by peripheral scotoma, group 2. Black on White Best Corrected Visual Acuity (BW-BCVA), White on Black Best Corrected Visual Acuity (WB-BCVA), Mars Contrast Sensitivity (CS) and a Glare Test (GT) were performed to all patients. Test results with blue-violet filter, a short-pass yellow filter and with no filters were compared. RESULTS: All scores from test results increased significantly with blue-violet filters for all patients. The mean BW-BCVA increased from 0.30 ± 0.20 to 0.36 ± 0.21 decimals in group 1 and from 0.44 ± 0.22 to 0.51 ± 0.23 decimals in group 2 (Mean ± SD, p < 0.0001 in both cases). The mean WB-BCVA increased from 0.31 ± 0.19 to 0.38 ± 0.23 decimals in group 1 and from 0.46 ± 0.20 to 0.56 ± 0.22 decimals in group 2 (Mean ± SD, p < 0.0001 in both cases). The letter count for the CS test increased from 26.7 ± 7.9 to 30.06 ± 7.8 in group 1 (Mean ± SD, p = 0.0005) and from 31.5 ± 7.6 to 33.72 ± 7.3 in group 2 (Mean ± SD, p = 0.031). GT was significantly reduced: the letter count increased from 20.93 ± 5.42 to 22.82 ± 4.93 in group 1 (Mean ± SD, p < 0.0001) and from 24.15 ± 5.5 to 25.97 ± 4.7 in group 2 (Mean ± SD, p < 0.0001). Higher scores were recorded with the Blue filter compared to Yellow filter in all tests (p < 0.05). No significant differences in any test results could be detected between the Yellow filter and the No filter condition. CONCLUSIONS: The use of a combination of photocromic lens with a selective blue-violet light filter showed functional benefit in all evaluated patients. BioMed Central 2017-08-22 /pmc/articles/PMC5568170/ /pubmed/28830379 http://dx.doi.org/10.1186/s12886-017-0545-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Colombo, L.
Melardi, E.
Ferri, P.
Montesano, G.
Samir Attaalla, S.
Patelli, F.
De Cillà, S.
Savaresi, G.
Rossetti, L.
Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title_full Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title_fullStr Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title_full_unstemmed Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title_short Visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
title_sort visual function improvement using photocromic and selective blue-violet light filtering spectacle lenses in patients affected by retinal diseases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568170/
https://www.ncbi.nlm.nih.gov/pubmed/28830379
http://dx.doi.org/10.1186/s12886-017-0545-9
work_keys_str_mv AT colombol visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT melardie visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT ferrip visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT montesanog visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT samirattaallas visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT patellif visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT decillas visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT savaresig visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases
AT rossettil visualfunctionimprovementusingphotocromicandselectivebluevioletlightfilteringspectaclelensesinpatientsaffectedbyretinaldiseases